blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3403098

EP3403098 - DIAGNOSTICS USING CONDITIONALLY ACTIVE ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.07.2022
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  20.08.2021
FormerGrant of patent is intended
Status updated on  25.04.2021
FormerExamination is in progress
Status updated on  10.03.2020
FormerRequest for examination was made
Status updated on  19.10.2018
FormerThe international publication has been made
Status updated on  21.07.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
BioAtla, Inc.
11085 Torreyana Road, Suite 100
San Diego, CA 92121 / US
[2021/33]
Former [2018/47]For all designated states
Bioatla, LLC
11085 Torreyana Road, Suite 100
San Diego, CA 92121 / US
Inventor(s)01 / SHORT, Jay M.
12985 Via Esperia
Del Mar California 92014 / US
 [2018/47]
Representative(s)De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
[2018/47]
Application number, filing date17738795.810.01.2017
[2018/47]
WO2017US12830
Priority number, dateUS201662277750P12.01.2016         Original published format: US 201662277750 P
[2018/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017123537
Date:20.07.2017
Language:EN
[2017/29]
Type: A1 Application with search report 
No.:EP3403098
Date:21.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 20.07.2017 takes the place of the publication of the European patent application.
[2018/47]
Type: B1 Patent specification 
No.:EP3403098
Date:22.09.2021
Language:EN
[2021/38]
Search report(s)International search report - published on:KR20.07.2017
(Supplementary) European search report - dispatched on:EP31.07.2019
ClassificationIPC:G01N33/574, G01N33/543, G01N33/536
[2018/47]
CPC:
G01N33/574 (EP); G01N33/57492 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:DIAGNOSTIKA MIT BEDINGT AKTIVEN ANTIKÖRPERN[2018/47]
English:DIAGNOSTICS USING CONDITIONALLY ACTIVE ANTIBODIES[2018/47]
French:DIAGNOSTICS À L'AIDE D'ANTICORPS CONDITIONNELLEMENT ACTIFS[2018/47]
Entry into regional phase30.07.2018National basic fee paid 
30.07.2018Search fee paid 
30.07.2018Designation fee(s) paid 
30.07.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
30.07.2018Examination requested  [2018/47]
20.02.2020Amendment by applicant (claims and/or description)
13.03.2020Despatch of a communication from the examining division (Time limit: M06)
22.09.2020Reply to a communication from the examining division
29.09.2020Despatch of a communication from the examining division (Time limit: M02)
08.12.2020Reply to a communication from the examining division
26.04.2021Communication of intention to grant the patent
16.08.2021Fee for grant paid
16.08.2021Fee for publishing/printing paid
16.08.2021Receipt of the translation of the claim(s)
Opposition(s)23.06.2022No opposition filed within time limit [2022/35]
Fees paidRenewal fee
28.01.2019Renewal fee patent year 03
27.01.2020Renewal fee patent year 04
27.01.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.01.2017
AL22.09.2021
AT22.09.2021
CY22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
MK22.09.2021
MT22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
SM22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
[2024/42]
Former [2024/22]HU10.01.2017
AL22.09.2021
AT22.09.2021
CY22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
MK22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
SM22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2024/21]HU10.01.2017
AL22.09.2021
AT22.09.2021
CY22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
SM22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2024/20]HU10.01.2017
AL22.09.2021
AT22.09.2021
CY22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2024/18]HU10.01.2017
AL22.09.2021
AT22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2023/10]AL22.09.2021
AT22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
IT22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2023/01]AL22.09.2021
AT22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SI22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2022/36]AL22.09.2021
AT22.09.2021
CZ22.09.2021
DK22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2022/29]AL22.09.2021
AT22.09.2021
CZ22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2022/24]AT22.09.2021
CZ22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RO22.09.2021
RS22.09.2021
SE22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
IS22.01.2022
PT24.01.2022
Former [2022/23]AT22.09.2021
CZ22.09.2021
EE22.09.2021
ES22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
PL22.09.2021
RS22.09.2021
SE22.09.2021
SK22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
PT24.01.2022
Former [2022/21]AT22.09.2021
FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
RS22.09.2021
SE22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
Former [2022/10]FI22.09.2021
HR22.09.2021
LT22.09.2021
LV22.09.2021
RS22.09.2021
SE22.09.2021
BG22.12.2021
NO22.12.2021
GR23.12.2021
Former [2022/09]FI22.09.2021
LT22.09.2021
RS22.09.2021
SE22.09.2021
BG22.12.2021
NO22.12.2021
Former [2022/08]FI22.09.2021
LT22.09.2021
SE22.09.2021
BG22.12.2021
NO22.12.2021
Former [2022/07]LT22.09.2021
NO22.12.2021
Documents cited:Search[A]WO2013134743  (HALOZYME INC [US]) [A] 1-17* page 238 *;
 [E]WO2017078839  (BIOATLA LLC [US]) [E] 1,9,10,13 * paragraph [0414] *;
 [E]WO2018044619  (BIOATLA LLC [US]) [E] 1,9,10,13 * paragraph [0484] *
International search[A]US2013052648  (YARMUSH MARTIN L [US], et al) [A] 1-12, 15-16, 18-30 , 36* See the whole document. *;
 [A]US2013266579  (WEI GE [US], et al) [A] 1-12, 15-16, 18-30 , 36 * See the whole document. *;
 [Y]US2014127290  (HE XIAOMING [US], et al) [Y] 2-11 * See claims 1 and 3-4; paragraphs [0007], [0036]-[0038], [0047] and [0060]. *;
 [Y]WO2015092726  (UNIVERSIT DEGLI STUDI DI UDINE [IT], et al) [Y] 1-12, 15-16, 18-30 , 36 * See claim 1; page 1, lines 19-23. *;
 [A]WO2015095603  (AXON DX LLC [US]) [A] 1-12, 15-16, 18-30 , 36 * See the whole document. *;
 [Y]WO2015175375  (SHORT JAY M [US], et al) [Y] 1-12, 15-16, 18-30 , 36 * See claims 1-2, 12, 31-34, 72-74 and 78; paragraphs [0175]-[0176], [0186]-[0187], [0204]-[0206] and [0334]. *
by applicantUS4353888
 US4391909
 US4689293
 US4803168
 US4806355
 US5227298
 US5573934
 US2002004587
 US2002098559
 US2004029241
 US2004086493
 US2004170612
 US6790455
 US6818230
 US2005037029
 US2005118425
 US2005202096
 US2005214377
 US7041504
 US2006251630
 US7297331
 US2009130718
 US2009214660
 US2009269313
 WO2010104821
 US2011064797
 US8039218
 US2012094275
 US8202701
 US2012164127
 US2012213708
 US2012231443
 US2012308650
 US8445225
 US2013277872
 WO2013170168
 US2014127290
 WO2014126904
 US2014271843
    - BUTLERGULLINO, Cancer Res., (19750000), vol. 35, pages 512 - 516
    - GILLIES et al., "MRI of the Tumor Microenvironment", Journal of Magnetic Resonance Imaging, (20020000), vol. 16, doi:10.1002/jmri.10181, pages 430 - 450, XP055045243

DOI:   http://dx.doi.org/10.1002/jmri.10181
    - SAKADZIC et al., "Two-photon high-resolution measurement of partial pressure of oxygen in cerebral vasculature and tissue", Nature Methods, (20100000), vol. 7, pages 755 - 759
    - SWARTS et al., "Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy", Cancer Res, (20120000), vol. 72, pages 2473 - 2480
    - ESTRELLA et al., "Acidity Generated by the Tumor Microenvironment Drives Local Invasion", Cancer Res., (20130000), vol. 73, doi:10.1158/0008-5472.CAN-12-2796, pages 1524 - 1535, XP055620422

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-12-2796
    - LORUSSO et al., "The tumor microenvironment and its contribution to tumor evolution toward metastasis", Histochem Cell Biol, (20080000), vol. 130, doi:10.1007/s00418-008-0530-8, pages 1091 - 1103, XP019657787

DOI:   http://dx.doi.org/10.1007/s00418-008-0530-8
    - GILLIES et al., "MRI of the Tumor Microenvironment", JOURNAL OF MAGNETIC RESONANCE IMAGING, (20020000), vol. 16, doi:10.1002/jmri.10181, pages 430 - 450, XP055045243

DOI:   http://dx.doi.org/10.1002/jmri.10181
    - MAYERS et al., "Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development", Nature Medicine, (20140000), vol. 20, pages 1193 - 1198
    - WEBER et al., "The tumor microenvironment", Surgical Oncology, (20120000), vol. 21, pages 172 - 177
    - BLAGOSKLONNY, "Antiangiogenic therapy and tumor progression", Cancer Cell, (20040000), vol. 5, pages 13 - 17
    - ESTRELLA et al., "Acidity Generated by the Tumor Microenvironment Drives Local Invasion", Cancer Research, (20130000), vol. 73, doi:10.1158/0008-5472.CAN-12-2796, pages 1524 - 1535, XP055620422

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-12-2796
    - BENJAMIN et al., "Measurement of soft tissue temperature and impedance following the application of transdermal direct current", Physiotherapy, (20070000), vol. 93, doi:10.1016/j.physio.2006.11.008, pages 114 - 120, XP022053862

DOI:   http://dx.doi.org/10.1016/j.physio.2006.11.008
    - DUNN-MEYNELL et al., "Relationship among Brain and Blood Glucose Levels and Spontaneous and Glucoprivic Feeding", The Journal of Neuroscience, (20090000), vol. 29, pages 7015 - 7022
    - HUR et al., "Quantitative Measurement of Organic Acids in Tissues from Gastric Cancer Patients Indicates Increased Glucose Metabolism in Gastric Cancer", PLoS ONE, (20140000), vol. 9, page e98581
    - ZATSEPIN et al., Russ. Chem. Rev., (20050000), vol. 74, pages 77 - 95
    - PHILLIPS et al., Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, (20080000), vol. 1, pages 69 - 83
    - ELBAYOUMI, T.A.TORCHILIN, V.P., Eur. J. Nucl. Med. Mol. Imaging, (20060000), vol. 33, pages 1196 - 1205
    - MOUGIN-DEGRAEF, M. et al., Int'l J. Pharmaceutics, (20070000), vol. 344, pages 110 - 117
    - TORCHILIN, V.P., Curr. Pharm. Biotech., (20000000), vol. 1, pages 183 - 215
    - BOGDANOV, A.A. et al., Adv. Drug Del. Rev., (19990000), vol. 37, pages 279 - 293
    - SACHSE, A., Investigative Radiology, (19970000), vol. 32, pages 44 - 50
    - VONA et al., "Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells", American Journal Of Pathology, (20000000), vol. 156, pages 57 - 63, XP002186868
    - "Complex Coacervation: Microcapsule Formation. In: Dubin", BURGESS, D. J., Macromolecular Complexes in Chemistry and Biology, Springer-Verlag, (19940000), pages 285 - 300
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.